Novartis announced disappointing sales for a key psoriasis drug and the looming retirement of its respected finance chief, which overshadowed a modest outlook raise. Novartis CEO Vasant Narasimham speaks with Bloomberg's Scarlet Fu on the impact of pharma tariffs.

Republican Senator Roger Marshall Talks Iran, DHS Funding
08:42

Rivian CEO RJ Scaringe Talks R2 Model
08:44

BMW North America CEO Sebastian Mackensen Talks New Luxury Car, Electric Vehicles
08:54